In vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial disease

Disease caused by nontuberculous mycobacteria (NTM) is increasing in frequency. The outcome of treatment for NTM lung disease is poor, particularly lung disease caused by Mycobacterium simiae and M. abscessus. Exploring synergy between active available drugs is a sensible way forward given the lack...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Antimicrobial agents and chemotherapy Jg. 56; H. 12; S. 6324
Hauptverfasser:	van Ingen, Jakko, Totten, Sarah E, Helstrom, Niels K, Heifets, Leonid B, Boeree, Martin J, Daley, Charles L
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.12.2012
Schlagworte:	Amikacin - pharmacology Amikacin - therapeutic use Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Clofazimine - pharmacology Clofazimine - therapeutic use Drug Synergism Microbial Sensitivity Tests Mycobacterium - drug effects Mycobacterium - growth & development Mycobacterium Infections - drug therapy Mycobacterium Infections - microbiology Nontuberculous Mycobacteria - drug effects Nontuberculous Mycobacteria - growth & development
ISSN:	1098-6596, 1098-6596
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!